Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran; Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Ann Thorac Surg. 2024 Jun;117(6):1145-1152. doi: 10.1016/j.athoracsur.2024.02.007. Epub 2024 Feb 14.
Although predictors and outcomes of postoperative atrial fibrillation (POAF) are well studied, evidence is lacking concerning postdischarge late/recurrent atrial fibrillation (AF). This study evaluated factors affecting late/recurrent AF and its association with coronary artery bypass grafting (CABG) outcomes in a real-world setting.
From 2012 through 2016, 5175 patients were included. Independent factors associated with late/recurrent AF were identified in a competing risk setting. Cox proportional hazard regression was used to evaluate the association between late/recurrent AF and study outcomes, consisting of all-cause mortality, major adverse cardio-cerebrovascular events, acute coronary syndrome, cerebrovascular events, and heart failure admissions.
During a median follow-up of 60 months (quartile 1-quartile 3, 59.3-60.7 months), late/recurrent AF developed in 85 patients (1.64%). Independent factors associated with late/recurrent AF were age (subdistribution hazard ratio [sHR], 1.04; 95% CI, 1.02-1.07), left-ventricular ejection fraction (sHR, 0.97; 95% CI, 0.95-0.99), length of stay (sHR, 1.02; 95% CI, 1.01-1.04), and POAF (sHR, 4.02; 95% CI, 2.50-6.45). Late/recurrent AF was not significantly associated with all-cause mortality and major adverse cardio-cerebrovascular events at unadjusted or adjusted levels (adjusted hazard ratio, 0.80 [95% CI, 0.50-1.28] and 0.74 [95% CI, 0.48-1.13], respectively). Nevertheless, it significantly increased the unadjusted risk of cerebrovascular events (hazard ratio, 2.28; 95% CI, 01.07-4.87), which disappeared after adjustments.
Patients with advanced age, a lower left-ventricular ejection fraction, and POAF are more likely to have late/recurrent clinical AF. Albeit counterintuitive, late/recurrent AF was not independently associated with worse midterm post-CABG outcomes. These observations need to be further elucidated in larger-scale studies and interpreted in the context of a developing country with limited resources for late AF surveillance.
尽管术后心房颤动(POAF)的预测因素和结果已经得到了很好的研究,但关于出院后晚期/复发性心房颤动(AF)的证据仍然缺乏。本研究评估了影响晚期/复发性 AF 的因素,并在真实环境中研究了其与冠状动脉旁路移植术(CABG)结果的关系。
2012 年至 2016 年期间,共纳入 5175 例患者。在竞争风险背景下确定与晚期/复发性 AF 相关的独立因素。使用 Cox 比例风险回归评估晚期/复发性 AF 与全因死亡率、主要不良心脑血管事件、急性冠状动脉综合征、脑血管事件和心力衰竭入院等研究结果之间的关系。
在中位随访 60 个月(四分位间距 1-3 分位间距,59.3-60.7 个月)期间,85 例患者(1.64%)出现晚期/复发性 AF。与晚期/复发性 AF 相关的独立因素为年龄(亚分布风险比[sHR],1.04;95%置信区间[CI],1.02-1.07)、左心室射血分数(sHR,0.97;95%CI,0.95-0.99)、住院时间(sHR,1.02;95%CI,1.01-1.04)和 POAF(sHR,4.02;95%CI,2.50-6.45)。晚期/复发性 AF 与未调整或调整后的全因死亡率和主要不良心脑血管事件无关(调整后的风险比分别为 0.80[95%CI,0.50-1.28]和 0.74[95%CI,0.48-1.13])。然而,它显著增加了未调整的脑血管事件风险(风险比,2.28;95%CI,01.07-4.87),调整后该风险消失。
年龄较大、左心室射血分数较低和 POAF 的患者更有可能出现晚期/复发性临床 AF。尽管有违直觉,但晚期/复发性 AF 与 CABG 术后中期预后无显著相关性。这些观察结果需要在更大规模的研究中进一步阐明,并在资源有限的发展中国家进行晚期 AF 监测的背景下进行解释。